• Pharmacycle celebrates having recycled 50 million blister packs
    Pharmacycle celebrates having recycled 50 million blister packs
Close×

Pharmacycle is celebrating having recycled 50 million blister packs since it began in 2022. This initiative targets the environmental impact of pharmaceutical packaging with over 870 drop-off points across Australia, including collaborations with Chemist Warehouse, independent pharmacies, local governments, and community groups.

In December 2024 alone, 3.4 million blister packs were recycled, contributing to this noteworthy achievement.

The program further extends its impact through partnerships with manufacturers like Think Fencing, which converts recycled materials into products like ONEDECK — a decking solution made from over 90 per cent recycled materials, including 30 per cent PVC from blister packs. Each metre of ONEDECK contains 600 grams of recycled blister pack plastic, about 400 blister packs.

For 2025, Pharmacycle plans to expand its network to enhance the accessibility of blister pack recycling and boost awareness through community engagement and educational content. The organisation also aims to support end manufacturers by promoting products made from recycled materials, reinforcing its commitment to closing the recycling loop.

Australians can contribute by collecting empty blister packs at home and dropping them off at designated locations. Pharmacycle encourages individuals to share their efforts and promote the initiative.

Food & Drink Business

This is your final call for the 2026 Hive Awards, entries close at 5pm TODAY – go, go, go!

Two of Australia’s peak business bodies have welcomed the federal government’s response to its Strategic Examination of Research and Development (SERD), but the Australian Industry Group (AiGroup) has raised sharp objections to a proposal it says will actively reduce the business R&D investment the report itself identifies as critically low.

A sweeping government review of Australia’s research and development system has recommended significant changes to tax incentives, manufacturing support and R&D funding to reshape how companies invest in innovation.